T, R., N, C., J, A., S, S., O, A., M, A., . . . TC, B. (2024). COVID-19 Stroke Apical Lung Examination Study 2: A national prospective CTA biomarker study of the lung apices, in patients presenting with suspected acute stroke (COVID SALES 2). NeuroImage. Clinical, 42, 103590. https://doi.org/10.1016/j.nicl.2024.103590
Chicago Style (17th ed.) CitationT, Ratneswaren, et al. "COVID-19 Stroke Apical Lung Examination Study 2: A National Prospective CTA Biomarker Study of the Lung Apices, in Patients Presenting with Suspected Acute Stroke (COVID SALES 2)." NeuroImage. Clinical 42 (2024): 103590. https://doi.org/10.1016/j.nicl.2024.103590.
MLA (9th ed.) CitationT, Ratneswaren, et al. "COVID-19 Stroke Apical Lung Examination Study 2: A National Prospective CTA Biomarker Study of the Lung Apices, in Patients Presenting with Suspected Acute Stroke (COVID SALES 2)." NeuroImage. Clinical, vol. 42, 2024, p. 103590, https://doi.org/10.1016/j.nicl.2024.103590.